Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients - Full Text View - ClinicalTrials.gov
Delayed-Action Preparations. Blood Glucose. Insulin. Alanine Transaminase. Aspartate Aminotransferases. Fructosamine. Glucose ... Molecular Mechanisms of Pharmacological Action. Lipid Regulating Agents. Vasodilator Agents. Vitamin B Complex. Vitamins. ...https://clinicaltrials.gov/show/NCT00046267?order=378
Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients - Full Text...
Delayed Action Preparations. Treatment Naive. HIV-1. Additional relevant MeSH terms: Infection. HIV Infections. Lentivirus ... Molecular Mechanisms of Pharmacological Action. Anti-HIV Agents. Anti-Retroviral Agents. Antiviral Agents. Anti-Infective ...https://clinicaltrials.gov/show/NCT00050895?order=228
Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected Women - Full Text View -...
Delayed-Action Preparations. Drug Interactions. Drug Therapy, Combination. Nevirapine. HIV Protease Inhibitors. Ritonavir. ... It is possible that this action may result in enhanced clearance of the substrates of CYP3A4, including PIs and nonnucleoside ... Molecular Mechanisms of Pharmacological Action. Anti-HIV Agents. Anti-Retroviral Agents. Antiviral Agents. Anti-Infective ...https://clinicaltrials.gov/show/NCT00016601?order=109
Depot Disulfiram for AIDS and ARC - Full Text View - ClinicalTrials.gov
Delayed-Action Preparations. Disulfiram. Acquired Immunodeficiency Syndrome. AIDS-Related Complex. Additional relevant MeSH ...https://clinicaltrials.gov/ct2/show/NCT00002065
A comparison of a new slow release aspirin ('slow aspirin') with plain aspirin in the treatment of rheumatoid disease.
Delayed-Action Preparations. Double-Blind Method. Drug Tolerance. Dyspepsia / chemically induced. Gastric Mucosa / drug effects ...http://www.biomedsearch.com/nih/comparison-new-slow-release-aspirin/881098.html
Long-term maintenance treatment in chronic schizophrenia. Some observations on outcome and duration.
Delayed-Action Preparations. Follow-Up Studies. Great Britain. Humans. Outcome and Process Assessment (Health Care). ... 0/Antipsychotic Agents; 0/Delayed-Action Preparations From MEDLINE®/PubMed®, a database of the U.S. National Library of ...http://www.biomedsearch.com/nih/Long-term-maintenance-treatment-in/6117186.html
Delayed-Action Preparations. Humans. Smoking Cessation*. Chemical. Reg. No./Substance: 0/Adrenergic beta-Agonists; 0/Delayed- ...http://www.biomedsearch.com/nih/Smoking-cessation/20849704.html
Pharmacokinetic studies with a dual-release formulation of levodopa, a novel principle in the treatment of Parkinson's disease.
Delayed-Action Preparations. Female. Food. Humans. Levodopa / adverse effects, pharmacokinetics, therapeutic use*. Male. ... 0/Antiparkinson Agents; 0/Delayed-Action Preparations; 0/Levodopa; 0/Tablets; 55520-40-6/Tyrosine; 7636-26-2/3-methoxytyrosine ...http://www.biomedsearch.com/nih/Pharmacokinetic-studies-with-dual-release/9520073.html
Treatment of urethral sphincter mechanism incompetence in 11 bitches with a sustained-release formulation of...
0/Delayed-Action Preparations; 14838-15-4/Phenylpropanolamine From MEDLINE®/PubMed®, a database of the U.S. National Library of ... Delayed-Action Preparations. Dog Diseases / drug therapy*. Dogs. Female. Phenylpropanolamine / blood, therapeutic use*. ...http://www.biomedsearch.com/nih/Treatment-urethral-sphincter-mechanism-incompetence/12403516.html
Pseudoephedrine hydrochloride sustained-release pellets prepared by a combination of hot-melt subcoating and polymer coating.
0/Delayed-Action Preparations; 90-82-4/Pseudoephedrine From MEDLINE®/PubMed®, a database of the U.S. National Library of ... Delayed-Action Preparations. Microscopy, Electron, Scanning. Pseudoephedrine / administration & dosage, chemistry*. Solubility ... 18709447 - Preparation of bmp-2 containing bovine serum albumin (bsa) nanoparticles stabilized by .... 18726187 - Corrosion ...http://www.biomedsearch.com/nih/Pseudoephedrine-hydrochloride-sustained-release-pellets/18785047.html
Practical application of pharmacotherapy with long-acting risperidone for patients with schizophrenia.
Delayed-Action Preparations / therapeutic use. Drug Tolerance. Health Promotion*. Humans. Patient Compliance*. Risperidone / ...http://www.biomedsearch.com/nih/Practical-application-pharmacotherapy-with-long/15345759.html
D Category Names List - Drug Information Portal - U.S. National Library of Medicine
Depot Preparations (0) see Delayed-Action Preparations. Dermatologic Agents (125) • Drugs used to treat or prevent skin ... Delayed-Action Preparations (3) • Dosage forms of a drug that act over a period of time by controlled-release processes or ... Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, ... Dopamine Antagonists (69) • Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine ...https://druginfo.nlm.nih.gov/drugportal/drug/categories/d
Assuring quality and performance of sustained and controlled release parenterals: workshop report.
0/Biopolymers; 0/Delayed-Action Preparations; 0/Solvents From MEDLINE®/PubMed®, a database of the U.S. National Library of ... Delayed-Action Preparations / classification, metabolism, pharmacokinetics, standards*. Drug Administration Routes. Drug ...http://www.biomedsearch.com/nih/Assuring-quality-performance-sustained-controlled/12141269.html
levodopa drug combination benserazide Summary Report | CureHunter
Delayed-Action Preparations 5. levodopa methyl ester 6. Carbidopa (Lodosyn) 7. Neurotransmitter Agents (Neurotransmitter) ... disease suffering nausea or vomiting as side-effects of levodopa therapy and compared the efficacy of the three preparations in ... disease suffering nausea or vomiting as side-effects of levodopa therapy and compared the efficacy of the three preparations in ...http://www.curehunter.com/public/keywordSummaryC005177-levodopa-drug-combination-benserazide.do
ESEM (a and b) images of aggregates of polymer nanopart | Open-i
Delayed-Action Preparations. *Drug Carriers. *Kinetics. *Microscopy, Electron, Scanning. *Microscopy, Electron, Transmission ... for obtaining core-coat nanoparticles with delayed release, have been elucidated. ... for obtaining core-coat nanoparticles with delayed release, have been elucidated. ...https://openi.nlm.nih.gov/detailedresult.php?img=PMC4048935_gr2&req=4
C Category Names List - Drug Information Portal - U.S. National Library of Medicine
Controlled-Release Preparations (0) see Delayed-Action Preparations. Convulsant Effect (0) see Convulsants ... The mechanism of action of many of these are as ALKYLATING AGENTS or MITOSIS MODULATORS. MeSH ... The many drugs that have such actions as side effects to their main therapeutic use are not included here. MeSH ... Those with specific mechanisms are classed by locus of action or specific therapeutic use. (From Gilman AG, et al., Goodman and ...https://druginfo.nlm.nih.gov/drugportal/drug/categories/c
Theoretical analysis of the release of slowly dissolving drugs from spherical matrix systems.
Algorithms, Delayed-Action Preparations, Diffusion, Kinetics, Microspheres, Models; Statistical, Pharmaceutical Preparations/* ...http://uu.diva-portal.org/smash/record.jsf?faces-redirect=true&language=sv&searchType=SIMPLE&query=&af=%5B%5D&aq=%5B%5B%5D%5D&aq2=%5B%5B%5D%5D&aqe=%5B%5D&pid=diva2%3A95451&noOfRows=50&sortOrder=author_sort_asc&sortOrder2=title_sort_asc&onlyFullText=false&sf=all
Oxytocin agonists for preventing postpartum haemorrhage | ScholarBank@NUS
Delayed-action preparations [therapeutic use]. Oxytocics [*therapeutic use]. Oxytocin [agonists; *analogs & derivatives; * ...https://scholarbank.nus.edu.sg/handle/10635/26044
Cytotoxicity of polyene-loaded antifungal fiber mats ag | Open-i
Delayed-Action Preparations/administration & dosage/chemistry*. *Fungi/drug effects/physiology*. *Gelatin/chemistry* ...https://openi.nlm.nih.gov/detailedresult.php?img=PMC4043707_ijn-9-2439Fig10&req=4
Kaplan-Meier estimates of all-cause mortality in COMET. | Open-i
Delayed-Action Preparations. *Drug Administration Schedule. *Heart Failure/drug therapy. *Hemodynamics/drug effects ... Bottom Line: However, vasodilatory beta-blockers such as carvedilol have a different hemodynamic action that provides the ... Bottom Line: However, vasodilatory beta-blockers such as carvedilol have a different hemodynamic action that provides the ... However, vasodilatory beta-blockers such as carvedilol have a different hemodynamic action that provides the benefits of beta- ...https://openi.nlm.nih.gov/detailedresult.php?img=PMC2663448_vhrm-4-1387f4&req=4
Health care use, drug treatment and comorbidity in patients with schizophrenia or non-affective psychosis in Sweden: a cross...
Delayed-action preparations. Background. Schizophrenia is a debilitating, often chronic, mental disorder that imposes a huge ...https://0-bmcpsychiatry-biomedcentral-com.brum.beds.ac.uk/articles/10.1186/s12888-017-1582-x
Jundishapur Journal of Natural Pharmaceutical Products - The Use of Natural Biopolymer of Chitosan as Biodegradable Beads for...
Keywords: Delayed-action Preparations; Teicoplanin; Chitosan; Cross-Linking Reagents Copyright © 2013, School of Pharmacy, ... 3. 2. Preparation of Chitosan Beads. Chitosan (1 and 2% w/v) was dissolved in an aqueous solution of 1% (w/v) acetic acid under ... The release of TN was more delayed compared to that of VM, which allowed a gradual release beyond 3 days. The half-life (mean ... Preparation and in vitro characterization of gentamycin-impregnated biodegradable beads suitable for treatment of osteomyelitis ...http://jjnpp.com/en/articles/18309.html
Patent US4716041 - Diffusion coated multiple-units dosage form - Google Patents
Processes for the preparation of delayed action and programmed release pharmaceutical forms and medicaments obtained thereby. ... Delayed, sustained-release propranolol pharmaceutical preparation. US5494681 *. 11 Aug 1994. 27 Feb 1996. Kv Pharmaceutical ... Preparation and Tabletting of Coated Cores. Preparation of Cores. Cores were prepared from the following ingredients:. ... Preparation of Film-Coated Potassium Chloride Crystals. Preparation of Inner Film-Coating Composition Containing a Hydrophobic ...http://www.google.com.au/patents/US4716041
Patent US4752470 - Controlled release indomethacin - Google Patents
Improvements to methods for preparing galenical preparation with delayed action and programmed release and galenical ... Delayed, sustained-release propranolol pharmaceutical preparation. US5500227 *. 23 Nov 1993. 19 Mar 1996. Euro-Celtique, S.A.. ... Delayed, sustained-release diltiazem pharmaceutical preparation. US6024982 *. 6 Jun 1995. 15 Feb 2000. Euro-Celtique, S.A.. ... Delayed, sustained-release pharmaceutical preparation. US5478573 *. 12 Dec 1994. 26 Dec 1995. Kinaform Technology, Inc.. ...http://www.google.com.au/patents/US4752470
Patent US5662935 - Process for preparing controlled release pharmaceutical forms and the forms ... - Google Patents
Depending on the employed excipient, a delayed or rapid but always controllable release of the active ingredient can be ... one or more active ingredients compatible with each other and with said excipients to mechanical or electromechanical actions ... Galenic delayed-action forms and method for their preparation. EP0080341A2 *. Nov 19, 1982. Jun 1, 1983. A/S Alfred Benzon. ... Delayed and sustained release type pharmaceutical preparation. US3492397 *. Apr 7, 1967. Jan 27, 1970. Warner Lambert ...http://www.google.com/patents/US5662935?dq=5726663